bemiparin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2018
024619982018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
INTRODUCTION The haemostatic system plays an important role in the process of cancer development and spread. Anticoagulants… (More)
Is this relevant?
2010
2010
BACKGROUND There is not enough clinical evidence to make a strong recommendation on the optimal duration of thromboprophylaxis… (More)
Is this relevant?
2008
2008
AIMS To assess the efficacy and safety of bemiparin in the treatment of chronic diabetic foot ulcers. METHODS A triple-blind… (More)
Is this relevant?
2004
2004
INTRODUCTION Low molecular weight heparins are effective and have a good tolerability profile as first-line prophylaxis for… (More)
Is this relevant?
2003
2003
In this randomized, multicenter, controlled, double-blind, sequential trial, 381 patients undergoing primary total knee… (More)
Is this relevant?
2002
2002
Human endothelial cells synthesize and secrete a variety of molecules involved in fibrinolysis and coagulation. The effects of a… (More)
Is this relevant?
2001
2001
OBJECTIVE Bemiparin is a new second generation low molecular weight heparin with a molecular weight of 3,600 daltons and an anti… (More)
Is this relevant?
2001
2001
We investigated the localisation, gene expression, and activity of tissue factor pathway inhibitor (TFPI) in endothelial cells… (More)
Is this relevant?
2000
2000
A randomised, prospective, double-blind trial was performed, to compare the safety and efficacy of a new low-molecular-weight… (More)
  • table 1
  • table 3
  • table 4
Is this relevant?
1998
1998
Low-molecular-mass heparins (LMMHs) exert an anti-FXa effect through antithrombin III (ATIII) and tissue factor pathway inhibitor… (More)
Is this relevant?